Growth Metrics

Nu-Med Plus (NUMD) EBT (2012 - 2025)

Nu-Med Plus recorded quarterly EBT of -$12618.0 in Q4 2025, down 5.45% quarter-over-quarter from -$11966.0 in Q3 2025, and down 19.55% year-over-year from -$15683.3 in Q4 2024.

Nu-Med Plus' EBT history runs 14 years deep, the most recent figure standing at -$12618.0 for Q4 2025.

  • In Q4 2025, EBT fell 19.55% year-over-year to -$12618.0; the TTM figure through Dec 2025 stood at -$56182.0 (up 17.8% YoY), while the FY2025 annual figure was -$56182.0, up 17.8% from the prior year.
  • EBT came in at -$12618.0 for Q4 2025 at Nu-Med Plus, down from -$11966.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $42606.0 in Q4 2022 to a low of -$356748.0 in Q1 2021.
  • A 5-year average of -$61133.2 and a median of -$23073.0 in 2023 frame the typical range for EBT.
  • Across the five-year window, EBT soared 137.93% in 2022 and slumped 232.84% in 2023, its largest moves.
  • Nu-Med Plus' EBT stood at -$112341.0 in 2021, then jumped by 137.93% to $42606.0 in 2022, then plunged by 232.84% to -$56596.0 in 2023, then jumped by 81.35% to -$10555.0 in 2024, then retreated by 19.55% to -$12618.0 in 2025.
  • According to Business Quant data, EBT over the past three periods registered -$12618.0, -$11966.0, and -$11665.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.45 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 850.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.40 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.16 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 459.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 222.44 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 269.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 505.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 304.50 Mn
10 Nu-Med Plus - - - -12,618.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -12,618.00
Sep 30, 2025 -11,966.00
Jun 30, 2025 -11,665.00
Mar 31, 2025 -19,933.00
Dec 31, 2024 -10,555.00
Sep 30, 2024 -18,677.00
Jun 30, 2024 -17,287.00
Mar 31, 2024 -21,826.00
Dec 31, 2023 -56,596.00
Sep 30, 2023 -16,406.00
Jun 30, 2023 -24,320.00
Mar 31, 2023 -28,204.00
Dec 31, 2022 42,606.00
Sep 30, 2022 -58,050.00
Jun 30, 2022 -58,070.00
Mar 31, 2022 -59,653.00
Dec 31, 2021 -112,341.00
Sep 30, 2021 -118,366.00
Jun 30, 2021 -251,990.00
Mar 31, 2021 -356,748.00
Dec 31, 2020 -507,696.00
Sep 30, 2020 -453,824.00
Jun 30, 2020 -912,488.00
Mar 31, 2020 -153,334.00
Dec 31, 2019 -209,881.00
Sep 30, 2019 -150,576.00
Jun 30, 2019 -239,386.00
Mar 31, 2019 -419,241.00
Dec 31, 2018 -350,409.00
Sep 30, 2018 -517,290.00
Jun 30, 2018 -163,871.00
Mar 31, 2018 -137,570.00
Dec 31, 2017 3.90 Mn
Sep 30, 2017 -132,521.00
Jun 30, 2017 -106,553.00
Mar 31, 2017 -65,823.00
Dec 31, 2016 938,770.00
Sep 30, 2016 -690,254.00
Jun 30, 2016 -172,446.00
Mar 31, 2016 -60,143.00
Dec 31, 2015 815,349.00
Sep 30, 2015 -299,358.00
Jun 30, 2015 -385,324.00
Mar 31, 2015 -114,747.00
Dec 31, 2014 -525,878.00
Sep 30, 2014 -234,924.00
Jun 30, 2014 -194,336.00
Mar 31, 2014 -144,347.00
Sep 30, 2013 -33,395.00
Jun 30, 2013 -31,139.00
Mar 31, 2013 -78,374.00
Dec 31, 2012 -266,403.00
Mar 31, 2012 -19,534.00